Skip to main content

November 2022: Alpha-1 Antitrypsin Deficiency Awareness Month

WHEREAS, Alpha-1 antitrypsin deficiency (Alpha-1) is a common, inherited condition that can cause chronic and progressive lung disease in adults and liver disease in both adults and children; and,

WHEREAS, Alpha-1 is seen in all ethnic groups but most commonly in people of European descent, affecting approximately 1 in 2,500 Americans; and,

WHEREAS, most cases of Alpha-1 go unrecognized, with only an estimated 10% of affected individuals diagnosed, stressing the importance of testing for this condition in all at-risk populations such as those with chronic obstructive pulmonary disease or unexplained liver disease; and,

WHEREAS, it is important to increase awareness and early detection of this underdiagnosed disorder so that treatments and lifestyle changes can be initiated to help prevent or slow serious disease; and,

WHEREAS, during the month of November, a nationwide awareness campaign will take place throughout the country to educate the public as well as the medical community about Alpha-1 detection and available treatments for those affected;

NOW, THEREFORE, I, Gretchen Whitmer, governor of Michigan, do hereby proclaim November 2022 as Alpha-1 Antitrypsin Deficiency Awareness Month in Michigan.